LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 21.74 | 2564 | 5768 | 0.4445 | 0.8084 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 21.74 | 2629 | 5768 | 0.4557 | 0.8140 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.45 | 21.74 | 2594 | 6023 | 0.4306 | 0.8028 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.45 | 21.74 | 2668 | 6023 | 0.4429 | 0.8090 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.45 | 21.74 | 2664 | 6023 | 0.4423 | 0.8087 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 57.45 | 21.74 | 2740 | 6023 | 0.4549 | 0.8150 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 59.42 | 21.74 | 2701 | 6125 | 0.4410 | 0.8086 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 59.42 | 21.74 | 2793 | 6125 | 0.4560 | 0.8160 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 59.42 | 21.74 | 2756 | 6125 | 0.4499 | 0.8131 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 59.42 | 21.74 | 2833 | 6125 | 0.4625 | 0.8192 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.39 | 21.74 | 2838 | 6112 | 0.4643 | 0.8200 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.39 | 21.74 | 2946 | 6112 | 0.4819 | 0.8284 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.39 | 21.74 | 2831 | 6112 | 0.4631 | 0.8194 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 62.39 | 21.74 | 2915 | 6112 | 0.4769 | 0.8260 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 64.36 | 21.74 | 2890 | 6191 | 0.4668 | 0.8216 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 64.36 | 21.74 | 3022 | 6191 | 0.4881 | 0.8316 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 64.36 | 21.74 | 2894 | 6191 | 0.4675 | 0.8219 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 64.36 | 21.74 | 3009 | 6191 | 0.4860 | 0.8306 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 66.33 | 21.74 | 2989 | 6235 | 0.4794 | 0.8277 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 66.33 | 21.74 | 3224 | 6235 | 0.5170 | 0.8448 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 66.33 | 21.74 | 2996 | 6235 | 0.4805 | 0.8283 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 66.33 | 21.74 | 3141 | 6235 | 0.5037 | 0.8389 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.30 | 21.74 | 2952 | 6244 | 0.4727 | 0.8247 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.30 | 21.74 | 3342 | 6244 | 0.5352 | 0.8526 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 68.30 | 21.74 | 3037 | 6244 | 0.4863 | 0.8310 | MN20160310_N01 | G04 |